RadNet, Inc. reported $2.27B of revenue over the trailing twelve months. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $2.27B (to Q2 2026). Net income: −$21M, trailing twelve months to Q2 2026. Free cash flow: $72M, trailing twelve months to Q2 2026. Operating margin: 3.1%, trailing twelve months to Q2 2026.

RDNTRadNet, Inc.

Healthcare

$70.89-7.3% 1Y

$70.89

$51.8752 weeks$84.48

RDNT as reported

RadNet, Inc. reported $2.27B of revenue over the trailing twelve months. 11 reported series are charted on this page, each one as filed.

$2.27B

Revenue, trailing twelve months · to Q2 2026 · every figure below is as filed, with no scoring applied

Net income: −$21M
Net income · +42% year on year · trailing twelve months to Q2 2026
Free cash flow: $72M
Free cash flow · −4.8% year on year · trailing twelve months to Q2 2026
Operating margin: 3.1%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for RDNT, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$2.27B	n/a	Q2 2026
Net income	−$21M	+42%	Q2 2026
EPS	−$0.27	+35%	Q2 2026
Gross margin	13%	n/a	Q4 2019 · 26 quarters behind
Operating margin	3.1%	n/a	Q2 2026
Net margin	−0.92%	n/a	Q2 2026
ROE	−1.5%	n/a	Q2 2026
ROA	−0.43%	n/a	Q2 2026
ROIC	3.2%	n/a	Q2 2026
Free cash flow	$72M	−4.8%	Q2 2026
P/E	102	n/a	Q4 2022 · 14 quarters behind

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.